Received Jun 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | X027728 | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
No additional AE; Caller confirmed that patient was not administered GARDASIL 9 same-day (missed dose); a patient who was inadvertently administered a pediatric dose of RECOMBIVAXHB instead of GARDASIL 9; This spontaneous report has been received from an other health professional, regarding to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported. On 10-JUN-2025, the patient who was inadvertently administered at a dose of Hepatitis B Vaccine (RECOMBIVAXHB) suspension for injection, at a dose of 0.5 milliliters (ml), lot number X027728, instead which has been verified to be valid, expiration date reported and established as 16-OCT-2026) route of administration, and anatomical site of injection were not provided) instead of Human Papillomavirus 9-valent (GARDASIL 9) (dose, route of administration, anatomical site of injection, lot number and expiration date were not reported), both vaccine administered as prophylaxis (Wrong product administered). Also, it was reported that the patient was not administered Human Papillomavirus 9-valent (GARDASIL 9) same-day (Product dose omission issue) and will come back a different day to continue vaccination with Human Papillomavirus 9-valent (GARDASIL 9). No additional adverse events were reported in the patient.